NASDAQ: RGNX - REGENXBIO

Yield per half year: -1.05%
Sector: Healthcare

REGENXBIO

Underestimation
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
8/10
12.54 48.77 -74.29% -3.02 -514.64%
P/S 9.02 33.76 -73.27%
P/BV 2.61 4.82 -45.81%
P/FCF -3.4 60.98 -105.57%
Ev/Ebitda -3.47 -22.12 -84.34%
Ev/S 9.63 22.56 -57.32%
Ev/FCF -3.81 68.75 -105.54%
E/P -0.3396 0.0178 -2010.69%
Efficiency
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-277.93 4.83 -5853.77% -222.35 24.99%
ROE -84.52 9.61 -979.88%
ROA -45.91 0.3359 -13766.73%
ROIC 17.5 7.63 129.23%
ROS -291.99 -25.17 1060.07%
ROCE -86.01 15.33 -661.01%
Debt
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.356 -3.67 -90.29% -0.2568 38.63%
Nеt Debt/Ebitda -0.2184 -3.44 -93.65%
Debt/Ratio 0.1556 0.1972 -21.09%
Debt/Equity 0.2146 1.54 -86.1%
Debt/Net Income -0.3389 10.31 -103.29%
Dividends
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5496 -100% 0 0%
Number of years of dividend growth 0 0.0789 -100%
DSI 0 0.2043 -100%
Average dividend growth 0 0.0591 -100%
Average percentage for 5 years 0 0.4924 -100%
Average percentage for payments 0 43.56 -100%
Difference from average difference in sector -0.5496
Growth impulse
Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue 5 years
10/10
156.37 -56.89 -374.86%
Growth impulse Ebitda 5 years 26.93 -64.81 -141.55%
Growth impulse Net Income 5 years 178.24 -58.33 -405.57%
Growth impulse FCF 5 years 91.26 -47 -294.17%
Growth impulse EPS 5 years 133.52 -32.41 -511.97%
IP Score
4.99/10

Similar companies

Amgen

Alexion

ABIOMED

Gilead Sciences